Login to Your Account

Innovation Analysis Part II

Darwin Denied: Study Shows Capital Drives Innovation

By Trista Morrison

Monday, April 2, 2012
The first part of BioWorld Insight's Innovation Analysis showed that while biotech Series A funding jumped 39 percent between 2010 and 2011, the percentage of that money allocated to so-called specialty pharma firms jumped 45 percent.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription